KR910021361A - 항궤양 물질 - Google Patents

항궤양 물질 Download PDF

Info

Publication number
KR910021361A
KR910021361A KR1019910002916A KR910002916A KR910021361A KR 910021361 A KR910021361 A KR 910021361A KR 1019910002916 A KR1019910002916 A KR 1019910002916A KR 910002916 A KR910002916 A KR 910002916A KR 910021361 A KR910021361 A KR 910021361A
Authority
KR
South Korea
Prior art keywords
trimethyl
cyclohepten
dihydroxy
preparation
ulcer
Prior art date
Application number
KR1019910002916A
Other languages
English (en)
Other versions
KR0169492B1 (ko
Inventor
기요까즈 무라까미
스스무 요꾸라
Original Assignee
노베 고지
도오꾜다나베세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노베 고지, 도오꾜다나베세이야꾸 가부시끼가이샤 filed Critical 노베 고지
Publication of KR910021361A publication Critical patent/KR910021361A/ko
Application granted granted Critical
Publication of KR0169492B1 publication Critical patent/KR0169492B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125Camphor; Nuclear substituted derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78Separation; Purification; Stabilisation; Use of additives
    • C07C45/79Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/717Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a seven- to twelve-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

내용 없음

Description

항궤양 물질
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 4, 5-디히드록시-2, 6, 6-트리메틸-2-시클로헵텐-1-온.
  2. 사이신을 유기용매로 추출하고, 이추출물을 용리액으로서 적당한 혼합용매를 사용하여 컬럼크로마토그래피하여 추출물을 정재하는 것을 특징을 하는 4. 5-디해드록시-2, 6, 6-트리메틸-2-시클로헵텐-1-온의 제조방법.
  3. 2, 6, 6-트리메틸시클로헵타-2, 4-디엔-1-온을 산화시켜 모노에폭사이드를 수득한후고리열림반응을 행하는 것을 특징으로 하는 4, 5-디히드록시-2, 6, 6-트리메틸-2-시클로헵텐-1-온의 제조방법.
  4. 유효성분으로서 4, 5-디히록시-2, 6, 6-트리메틸-2-시클로헵텐-1-온을 함유하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019910002916A 1990-02-22 1991-02-22 항궤양 물질 KR0169492B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP39663/1990 1990-02-22
JP3966390 1990-02-22
JP39663/90 1990-02-22
JP325333/1990 1990-11-29
JP325333/90 1990-11-29
JP2325333A JPH0745426B2 (ja) 1990-02-22 1990-11-29 新規抗潰瘍物質

Publications (2)

Publication Number Publication Date
KR910021361A true KR910021361A (ko) 1991-12-20
KR0169492B1 KR0169492B1 (ko) 1999-03-20

Family

ID=26379045

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910002916A KR0169492B1 (ko) 1990-02-22 1991-02-22 항궤양 물질

Country Status (8)

Country Link
EP (1) EP0443848B1 (ko)
JP (1) JPH0745426B2 (ko)
KR (1) KR0169492B1 (ko)
AT (1) ATE111883T1 (ko)
AU (1) AU633402B2 (ko)
DE (1) DE69104083T2 (ko)
DK (1) DK0443848T3 (ko)
ES (1) ES2060293T3 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU650360B2 (en) * 1991-08-21 1994-06-16 Mitsubishi-Tokyo Pharmaceuticals, Inc. Saishin N derivatives, process for preparing same and antiulcer agents containing same
US5610294A (en) 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
USRE37781E1 (en) 1991-10-11 2002-07-02 Dupont Pharmaceuticals Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5616578A (en) * 1993-08-26 1997-04-01 The Dupont Merck Pharmaceutical Company Method of treating human immunodeficiency virus infection using a cyclic protease inhibitor in combination with a reverse transcriptase inhibitor
CA2212381A1 (en) * 1995-04-12 1996-10-17 Masao Yajima 4-amino-5-oxy-2,6,6-trimethyl-2-cycloheptene compounds
US6313110B1 (en) 1999-06-02 2001-11-06 Dupont Pharmaceuticals Company Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor
US6737087B2 (en) * 2001-03-13 2004-05-18 Sung-jin Kim Composition containing Asiasari Radix extracts for protecting brain cells and improving memory
KR20030012002A (ko) * 2001-07-30 2003-02-12 진양제약주식회사 세신엑스 연질캅셀
KR100462788B1 (ko) 2001-11-06 2004-12-20 김성진 천초 추출물을 함유하는 뇌세포 보호 및 기억력 증진용조성물
JP4973210B2 (ja) * 2006-11-14 2012-07-11 東亞合成株式会社 新規合成方法
JP6454217B2 (ja) * 2014-05-13 2019-01-16 積水化学工業株式会社 変性ジアルキルアミノ安息香酸系化合物、変性チオキサントン誘導体、光硬化性樹脂組成物、液晶表示素子用シール剤、上下導通材料、及び、液晶表示素子

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749681A (en) * 1986-05-22 1988-06-07 International Flavors & Fragrances Inc. Polyalkyl-substituted oxocycloheptane derivatives, organoleptic uses thereof and processes for preparing same

Also Published As

Publication number Publication date
DK0443848T3 (da) 1994-10-17
AU633402B2 (en) 1993-01-28
ATE111883T1 (de) 1994-10-15
DE69104083D1 (de) 1994-10-27
JPH0745426B2 (ja) 1995-05-17
ES2060293T3 (es) 1994-11-16
JPH03275640A (ja) 1991-12-06
KR0169492B1 (ko) 1999-03-20
EP0443848B1 (en) 1994-09-21
EP0443848A1 (en) 1991-08-28
AU7125991A (en) 1991-08-29
DE69104083T2 (de) 1995-06-22

Similar Documents

Publication Publication Date Title
HUT50786A (en) Process for producing new condensed heterocyclic compounds and pharmaceutical compositions containing them as active components
SE8700498D0 (sv) Novel pharmaceologically active compounds
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
KR910021361A (ko) 항궤양 물질
SE8404065D0 (sv) Novel biologically active compounds
FR2362839A1 (fr) Derives de l'hydantoine et medicaments contenant ces substances
SE8600658D0 (sv) Novel composition of matter
ATE5188T1 (de) Phenylalkansaeure-derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
KR880012226A (ko) 외 용 제
KR890009395A (ko) 흡입제
SE9004169D0 (sv) Anvaendning av farmaceutiska och kosmetiska kompositioner, innehaallande 1,8-dihydroxi-10-fenyl-9-antron som verksam bestaandsdel
DK89289D0 (da) Anvendelse af 1,4-dihydropyridin-derivater til fremstilling af laegemiddel til afvaenning af alkoholister
PT70107A (fr) Procede de preparation de nouveaux derives de 1,3-benzoxazine-2,4-dione et des compositions pharmaceutiques les contenant
KR890001543A (ko) 당뇨병 치료제
KR890001556A (ko) 약제학적 조성물
KR920701221A (ko) 신규한 백금 착체 및 이를 유효성분으로 하는 항종양제
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
KR880012228A (ko) 천식 치료제
BE878824A (fr) Derives de 3,4-dihydroxy-cinnamaldehyde, procede pour sa preparation et medicament le contenant
KR920011499A (ko) 여드름 치료용 조성물
JPS537697A (en) 3-phenylhydantoic acid derivatives, their preparation and nonmedical fungicides containing the same as active constituents
KR890014101A (ko) 동맥경화증 치료제
KR890001582A (ko) 향류머티스제

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee